|Ms. Kate Quirke||MD, CEO & Exec. Director||430.25k||N/A||N/A|
|Mr. Raymond Howard Blight||Co-Founder & Non-Exec. Director||397.35k||N/A||N/A|
|Mr. Colin Bruce MacKinnon||CFO & COO||1.1M||N/A||N/A|
|Prof. Malcolm Pradhan||Chief Medical Officer, Product Mang. & Exec. Director||298.12k||N/A||N/A|
|Ms. Tracey Harvey||HR Mang.||N/A||N/A||N/A|
Alcidion Group Limited engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision that combines artificial intelligence-based predictive analytics, clinical decision support, and mobile alerts in analytics dashboard; Patientrack, a patient safety and communication systems putting clinicians in control; and Smartpage, a messaging and task management platform that enables hospital staff to communicate and collaborate. It also provides project management, consulting, and support services for digital health projects. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. The company was founded in 2000 and is headquartered in South Yarra, Australia.
Alcidion Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.